LPS SR 200 Tablet contains Progesterone (Natural Micronized) 200 mg, a vital hormone used primarily in hormone replacement therapy and the management of various gynecological conditions. Progesterone is essential for regulating the menstrual cycle, maintaining pregnancy, and supporting the luteal phase in assisted reproductive technologies. The micronized form enhances bioavailability, ensuring effective absorption and therapeutic action. LPS SR 200 is indicated for the treatment of progesterone deficiency, luteal phase support in infertility treatments, prevention of threatened miscarriage, and management of secondary amenorrhea. It is also utilized in hormone replacement therapy for menopausal symptoms and endometrial protection when combined with estrogen therapy. The sustained-release formulation allows for a controlled and prolonged release of progesterone, maintaining stable plasma levels and improving patient compliance by reducing dosing frequency. Administration should be as per physician guidance, considering individual patient needs and clinical response. Common side effects may include mild gastrointestinal discomfort, headache, dizziness, and breast tenderness. Contraindications include known hypersensitivity to progesterone, active thrombophlebitis, or hormone-dependent malignancies. Regular monitoring is recommended during therapy to assess efficacy and detect any adverse effects. LPS SR 200 Tablet offers a reliable option for progesterone supplementation in various clinical scenarios requiring hormonal modulation.